Haller Julia A
SEC insider (Form 3/4/5 filer). CIK 0001656082. Director at BRISTOL MYERS SQUIBB CO (BMY) and 1 other issuer. 8 reported Form 4/5 transactions since Sep 2024; latest on Jun 15, 2026. Located in PRINCETON, NJ.
Companies Haller Julia A has filed insider reports for
- BRISTOL MYERS SQUIBB CO (BMY): Director
- Outlook Therapeutics, Inc. (OTLK): Director
Haller Julia A
CIK: 0001656082
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Jun 15, 2026BMY
BRISTOL MYERS SQUIBB CO
ExerciseDirect20.5K shares at avg. $53.76$1.1M - Feb 1, 2026BMY
BRISTOL MYERS SQUIBB CO
AwardDirectDeferred Share Units
4K shares at avg. $55.05- - Oct 3, 2025OTLK
Outlook Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
58.6K shares- - Oct 1, 2025OTLK
Outlook Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
286.7K shares- - Feb 1, 2025BMY
BRISTOL MYERS SQUIBB CO
AwardDirectDeferred Share Units
3.6K shares at avg. $58.95- - Oct 3, 2024OTLK
Outlook Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
12.1K shares- - Oct 1, 2024OTLK
Outlook Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
56.6K shares- - Oct 1, 2024OTLK
Outlook Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
47.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 15, 2026 |  BMY BRISTOL MYERS SQUIBB CO | Exercise | 20,460 | $53.76 | $1,099,930 | Direct |
| Feb 1, 2026 | BMY BRISTOL MYERS SQUIBB CO | Award Deferred Share Units | 3,996 | $55.05 | - | Direct |
| Oct 3, 2025 |  OTLK Outlook Therapeutics, Inc. | Award Stock Option (Right to Buy) | 58,648 | - | - | Direct |
| Oct 1, 2025 | OTLK Outlook Therapeutics, Inc. | Award Stock Option (Right to Buy) | 286,734 | - | - | Direct |
| Feb 1, 2025 | BMY BRISTOL MYERS SQUIBB CO | Award Deferred Share Units | 3,562 | $58.95 | - | Direct |
| Oct 3, 2024 | OTLK Outlook Therapeutics, Inc. | Award Stock Option (Right to Buy) | 12,082 | - | - | Direct |
| Oct 1, 2024 | OTLK Outlook Therapeutics, Inc. | Award Stock Option (Right to Buy) | 56,636 | - | - | Direct |
| Oct 1, 2024 | OTLK Outlook Therapeutics, Inc. | Award Stock Option (Right to Buy) | 47,232 | - | - | Direct |
1-8 of 8 transactions